Web13 Apr 2024 · SEEL Stock Overview. Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of … Web15 Dec 2024 · NEW YORK, Dec. 15, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital has selected Seelos' …
Seelos Therapeutics Announces the Selection of SLS-005 …
WebThe Sean M. Healey & AMG Center for ALS at Mass General has received approval from the U.S. Food and Drug Administration (FDA) to proceed with administering three proposed … Web22 Dec 2024 · Treatment will last 24 weeks. “We are excited to work with Seelos and look forward to studying SLS-005 in an accelerated format through the HEALEY ALS Platform Trial,” said Merit Cudkowicz, MD, director of the Sean M. Healey Center, and principal investigator of HEALEY. installing unity 5.5 on max
Seelos Therapeutics Doses the First Amyotrophic Lateral …
Web4 Apr 2024 · NEW YORK, April 4, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the … Web25 Apr 2024 · Our Board of Directors has each established their leadership in the industry. Raj Mehra, Ph.D., Chairman, founder, and CEO of Seelos will serve as the Chairman, CEO, and President. Dr. Mehra is joined by Richard Pascoe, CEO, KemPharm, Inc.; Margaret Dalesandro, PhD, Founder and President, Brecon Pharma Consulting LLC.; Web28 Feb 2024 · NEW YORK, Feb. 28, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of … installing uniclic flooring